Alternatives to ProtOS.bio

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-driven platform for protein-level disease mapping and drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Synthetic biology platform for environmental sustainability solutions.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

AI-powered epiproteomic analysis platform for mass spectrometry data.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Drug discovery and development company using a novel technological approach.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

AI-driven predictive modeling company focused on biology and life sciences.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Building General Biological Intelligence

Unleashing the power of genomics at scale for biological advances and human health.

AI-enabled technology for cell biology research and biopharma development.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing novel therapeutics for rare genetic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Advanced infectious disease diagnostics

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Accelerating the development of breakthrough new medicines and medical technologies.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing sex reversal technology for the broiler industry to improve economic efficiency and increase male broiler production.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base